Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Mayo Clinic
Kivu Bioscience Inc.
STORM Therapeutics LTD
Eli Lilly and Company
Terremoto Biosciences Inc.
Jazz Pharmaceuticals
AstraZeneca
Seagen Inc.
Radiopharm Theranostics, Ltd
Arvinas Inc.
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
Daiichi Sankyo
Solve Therapeutics
University of Nebraska
Adela, Inc
Radiopharm Theranostics, Ltd
Elephas
Elephas
GlaxoSmithKline
Fate Therapeutics
Tanabe Pharma America, Inc.
West China Hospital
Volastra Therapeutics, Inc.
M.D. Anderson Cancer Center
LigaChem Biosciences, Inc.
Guardant Health, Inc.
Totus Medicines
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
UNICANCER
Pack Health
Innolake Biopharm
Hospices Civils de Lyon